Study on Tailored Treatment in Elderly Patients With Newly Diagnosed Primary Lymphoma of Central Nervous System
Clinical trial NCT03495960 · COMPLETED
Trial details
- NCT number
- NCT03495960
- Sponsor
- International Extranodal Lymphoma Study Group (IELSG)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-15
- Primary completion
- 2024-12-12
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.